Literature DB >> 10707016

Lyophilization of cationic lipid-protamine-DNA (LPD) complexes.

B Li1, S Li, Y Tan, D B Stolz, S C Watkins, L H Block, L Huang.   

Abstract

Cationic lipid-based gene delivery systems have shown promise in transfecting cells both in vitro and in vivo. However, these systems tend to form aggregates in liquid formulation during storage, which has limited their clinical applications. As a result, lyophilization of these systems has recently become a subject of increasing interest. In this paper, lyophilization of LPD, a novel cationic lipid-based gene delivery system, was studied. Both particle size and transfection efficiency could be preserved in the presence of sufficient amount of appropriate lyoprotectant. A series of monosaccharides and disaccharides, including dextrose, galactose, mannose, lactose, maltose, sucrose and trehalose, were evaluated for their lyoprotective effect and disaccharides showed more superior protection to monosaccharides. The effect of different freezing protocols for lyophilization was also evaluated and no significant difference was found. However, for freeze-thawing, fast freezing caused less aggregation. Finally, nonlyophilized LPD and LPD lyophilized with 10% sucrose were stored at different temperatures and their stability was followed for eight weeks. Lyophilized LPD could be stored at room temperature without significant change in particle size or loss of transfection efficiency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10707016     DOI: 10.1002/(SICI)1520-6017(200003)89:3<355::AID-JPS7>3.0.CO;2-H

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  17 in total

1.  Transfection efficiency of pORF lacZ plasmid lipopolyplex to hepatocytes and hepatoma cells.

Authors:  Xun Sun; Hong-Wei Zhang; Zhi-Rong Zhang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

2.  Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use.

Authors:  Sherry Y Wu; Lisa N Putral; Mingtao Liang; Hsin-I Chang; Nigel M Davies; Nigel A J McMillan
Journal:  Pharm Res       Date:  2008-11-21       Impact factor: 4.200

3.  A covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide delivery.

Authors:  Xiaojuan Yang; Yong Peng; Bo Yu; Jianhua Yu; Chenguang Zhou; Yicheng Mao; L James Lee; Robert J Lee
Journal:  Mol Pharm       Date:  2011-03-23       Impact factor: 4.939

4.  Relationships between liposome properties, cell membrane binding, intracellular processing, and intracellular bioavailability.

Authors:  Yinghuan Li; Jie Wang; Yue Gao; Jiabi Zhu; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2011-09-10       Impact factor: 4.009

5.  Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine-DNA particles.

Authors:  Brian R Sloat; Zhengrong Cui
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

6.  Intracellular trafficking pathways involved in the gene transfer of nano-structured calcium phosphate-DNA particles.

Authors:  Dana Y E Olton; John M Close; Charles S Sfeir; Prashant N Kumta
Journal:  Biomaterials       Date:  2011-07-19       Impact factor: 12.479

Review 7.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12

8.  Stabilization of aerosolizable nano-carriers by freeze-drying.

Authors:  Claudia B Packhaeuser; Kerstin Lahnstein; Johannes Sitterberg; Thomas Schmehl; Tobias Gessler; Udo Bakowsky; Werner Seeger; Thomas Kissel
Journal:  Pharm Res       Date:  2008-10-08       Impact factor: 4.200

9.  Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor.

Authors:  Zhengrong Cui; Su-Ji Han; Leaf Huang
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

10.  Gemcitabine nanoparticles promote antitumor immunity against melanoma.

Authors:  Yuan Zhang; Xin Bush; Bingfang Yan; Justin A Chen
Journal:  Biomaterials       Date:  2018-10-20       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.